Fairfield Financial Advisors, LTD
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2033232
WELLESLEY, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$545,409
+$55,109 QoQ
Shares Held
1,098
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,041
of 1,735 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fairfield Financial Advisors, LTD holds $545,409 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,098 | $545,409 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $545,409 | 1,098 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $490,300 | 1,098 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $497,789 | 1,098 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $290,988 | 743 | Shares | Sole | 2025-10-24 | |
| 2024-12-31 | $144,972 | 360 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $169,754 | 365 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $176,238 | 376 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $144,445 | 355 | Shares | Sole | 2024-11-04 | |
| 2023-09-30 | $123,447 | 355 | Shares | Sole | 2024-11-04 | |
| 2023-06-30 | $124,928 | 355 | Shares | Sole | 2024-11-04 | |
| 2023-03-31 | $111,849 | 355 | Shares | Sole | 2024-11-04 | |
| 2022-12-31 | $102,516 | 355 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $102,786 | 355 | Shares | Sole | 2024-10-07 | |
| 2022-06-30 | $100,035 | 355 | Shares | Sole | 2024-10-07 | |
| 2022-03-31 | $103,083 | 395 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||